1. Stone, GW, Selker, HP, Thiele, H, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674–1683.
Google Scholar | Crossref | Medline2. Kloner, RA, Alker, K, Campbell, C, Figures, F, Eisenhauer, A, Hale, S. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi? Circulation. 1989;79(5):1125–1136.
Google Scholar | Crossref | Medline3. Romson, JL, Bush, LR, Jolly, SE, Lucchesi, BR. Cardioprotective effects of ibuprofen in experimental regional and global myocardial ischemia. J Cardiovasc Pharmaco. 1982;4(2):187–196.
Google Scholar | Crossref | Medline4. Kloner, RA, Fishbein, MC, Lew, H, Maroko, PR, Braunwald, E. Mummification of the infarcted myocardium by high dose corticosteroids. Circulation. 1978;57:56–63.
Google Scholar | Crossref | Medline | ISI5. Hammerman, H, Kloner, RA, Hale, S, Schoen, FJ, Braunwald, E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation. 1983;68(2):446–452.
Google Scholar | Crossref | Medline6. Brown, EJ, Kloner, RA, Schoen, FJ, Hammerman, H, Hale, S, Braunwald, E. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol. 1983;51(5):877–883.
Google Scholar | Crossref | Medline7. Hammerman, H, Kloner, RA, Schoen, FJ, Brown, EJ, Hale, S, Braunwald, E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation. 1983;67(6):1290–1295.
Google Scholar | Crossref | Medline8. Hammerman, H, Schoen, FJ, Braunwald, E, Kloner, RA. Drug-induced expansion of infarct: morphologic and functional correlations. Circulation. 1984;69(3):611–617.
Google Scholar | Crossref | Medline9. Weisman, HF, Healy, B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987:30(2):73–110.
Google Scholar | Crossref | Medline10. Peters, RW, Norman, A, Parmley, WW, Emilson, BB, Scheinman, MM, Cheitlin, M. Effect of therapy with methylprednisolone on the size of myocardial infarcts in man. Chest. 1978;73(4):483–488.
Google Scholar | Crossref | Medline11. Bush, CA, Renner, W, Boudoulas, H. Corticosteroids in acute myocardial infarction. Angiology. 1980;31(10):710–714.
Google Scholar | SAGE Journals | ISI12. Giugliano, GR, Giugliano, RP, Gibson, CM, Kuntz, RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol. 2003;91(9):1055–1059.
Google Scholar | Crossref | Medline13. Gerczuk, PZ, Kloner, RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol. 2012;59(11):969–978.
Google Scholar | Crossref | Medline14. Libby, P, Ridker, PM, Maseri, A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–1143.
Google Scholar | Crossref | Medline | ISI15. Nidorf, SM, Fiolet, ATL, Mosterd, A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838–1847.
Google Scholar | Crossref | Medline16. Ridker, PM, Everett, BM, Thuren, T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131.
Google Scholar | Crossref | Medline17. Abbate, A, Trankle, CR, Buckley, LF, et al. Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment–elevation myocardial infarction. J Am Heart Assoc. 2020;9(5):e014941. doi:10.1161/JAHA.119.014941
Google Scholar | Crossref | Medline18. Gabriel, AS, Martinsson, A, Wretlind, B, Ahnve, S. IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Intern Med. 2004;15(8):523–528.
Google Scholar | Crossref | Medline19. Kleveland, O, Kuntszt, G, Bratlie, M, et al. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J. 2016;37(30):2406–2413.
Google Scholar | Crossref | Medline20. Broch, K, Anstensrud, AK, Woxholt, S, et al. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2021;77(15):1845–1855.
Google Scholar | Crossref | Medline21. Abatte, A, Kontos, MC, Abouzaki, NA, et al. Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from VCU-ART and VCU-ART2 pilot studies). Am J Cardiol. 2015;115(3):288–292.
Google Scholar | Crossref | Medline22. Tardif, J-C, Kouz, S, Waters, DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497–2505.
Google Scholar | Crossref | Medline23. Tong, DC, Quinn, S, Nasis, A, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020;142:1890–1900.
Google Scholar | Crossref | Medline